Quantitative analysis of hyperpolarized 129Xe ventilation imaging in healthy volunteers and subjects with chronic obstructive pulmonary disease

NMR in Biomedicine

Volumn 26, Issue 4, 2013, Pages 424-435

  Virgincar, Rohan S ^a,b   Cleveland, Zackary I ^a   Sivaram Kaushik, S ^a,b   Freeman, Matthew S ^a,c   Nouls, John ^a   Cofer, Gary P ^a   Martinez Jimenez, Santiago ^a   He, Mu ^a,b   Kraft, Monica ^a   Wolber, Jan ^d,e   Page Mcadams, H ^a   Driehuys, Bastiaan ^a,b,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Duke University   (United States)

^c DUKE UNIVERSITY   (United States)

^d GE HEALTHCARE   (United Kingdom)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

129Xe; Coefficient of variation; COPD; Defect; Hyperpolarized; MRI; Segmentation; Ventilation

Indexed keywords

AGE-MATCHED CONTROLS; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; COEFFICIENT OF VARIATION; COPD; HYPERPOLARIZED; PULMONARY FUNCTION TEST; SEMI-AUTOMATED ANALYSIS; VENTILATION PATTERNS;

DEFECTS; GRAPHIC METHODS; IMAGE SEGMENTATION; MAGNETIC RESONANCE IMAGING; PULMONARY DISEASES; STATISTICAL METHODS; XENON;

VENTILATION;

CONTRAST MEDIUM; UNCLASSIFIED DRUG; XENON 129; XENON;

AGE; AGED; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONSENSUS; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HISTOGRAM; HUMAN; HYPERPOLARIZATION; IMAGE ANALYSIS; LUNG FUNCTION TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOLOGIST; THORACIC CAVITY; VENTILATED PATIENT; VOLUNTEER; ADULT; AUTOMATION; CASE CONTROL STUDY; DIAGNOSTIC USE; LUNG VENTILATION; NORMAL HUMAN; OBSERVER VARIATION; PATHOPHYSIOLOGY; PROTON NUCLEAR MAGNETIC RESONANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ADULT; AGE FACTORS; AUTOMATION; CASE-CONTROL STUDIES; FEMALE; HEALTHY VOLUNTEERS; HUMANS; MALE; OBSERVER VARIATION; PROTON MAGNETIC RESONANCE SPECTROSCOPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY VENTILATION; RESPIRATORY FUNCTION TESTS; XENON ISOTOPES;

EID: 84875051321     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2880     Document Type: Article

References (40)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease - GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007; 176(6): 532-555.
2. Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, Brusasco V, Burge PS, Calverley PMA, Celli BR, Jones PW, Mahler DA, Make B, Miravitiles M, Page CP, Palange P, Parr D, Pistolesi M, Rennard SI, Molken M, Stockley R, Sullivan SD, Wedzicha JA, Wouters EF. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur. Respir. J. 2008; 31(2): 416-468.
3. Mahler DA, Mackowiak JI. Evaluation of the short-form 36-item questionnaire to measure health-related quality-of-life in patients with COPD. Chest 1995; 107(6): 1585-1589.
4. Nishimura K, Izumi T, Tsukino M, Oga T, Japan KCRRG. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121(5): 1434-1440.
5. Ashutosh K, Haldipur C, Boucher ML. Clinical and personality profiles and survival in patients with COPD. Chest 1997; 111(1): 95-98.
6. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am. J. Respir. Crit. Care Med. 2010; 182(5): 598-604.
7. Moller HE, Chen XJ, Saam B, Hagspiel KD, Johnson GA, Altes TA, de Lange EE, Kauczor HU. MRI of the lungs using hyperpolarized noble gases. Magn. Reson. Med. 2002; 47(6): 1029-1051.
8. Lutey BA, Lefrak SS, Woods JC, Tanoli T, Quirk JD, Bashir A, Yablonskiy DA, Conradi MS, Bartel ST, Pilgram TK, Cooper JD, Gierada DS. Hyperpolarized He-3 MR imaging: physiologic monitoring observations and safety considerations in 100 consecutive subjects. Radiology 2008; 248(2): 655-661.
9. Salerno M, de Lange EE, Altes TA, Truwit JD, Brookeman JR, Mugler JP. Emphysema: hyperpolarized helium 3 diffusion MR imaging of the lungs compared with spirometric indexes-initial experience. Radiology 2002; 222(1): 252-260.
10. 3He diffusion MRI and histology in pulmonary emphysema. Magn. Reson. Med. 2006; 56(6): 1293-1300.
11. 3He MR imaging. Radiology 2006; 239(3): 875-883.
12. Woodhouse N, Wild JM, Paley MNJ, Fichele S, Said Z, Swift AJ, van Beek EJR. Combined helium-3/proton magnetic resonance imaging measurement of ventilated lung volumes in smokers compared to never-smokers. J. Magn. Reson. Imaging 2005; 21(4): 365-369.
13. 3He-enhanced and conventional proton MR imaging in the lung-preliminary observations. Radiology 1999; 212(3): 885-889.
14. 3helium magnetic resonance ventilation imaging of the lung in cystic fibrosis: comparison with high resolution CT and spirometry. Eur. Radiol. 2006; 16(11): 2483-2490.
15. de Lange EE, Altes TA, Patrie JT, Gaare JD, Knake JJ, Mugler JP, Platts-Mills TA. Evaluation of asthma with hyperpolarized helium-3 MRI: correlation with clinical severity and spirometry. Chest 2006; 130(4): 1055-1062.
16. 3He magnetic resonance imaging: preliminary evaluation of phenotyping potential in chronic obstructive pulmonary disease. Eur. J. Radiol. 2011; 79(1): 140-146.
17. 3He magnetic resonance imaging of chronic obstructive pulmonary disease: reproducibility at 3.0 tesla. Acad. Radiol. 2008; 15(10): 1298-1311.
18. 3He magnetic resonance imaging of ventilation defects in healthy elderly volunteers: initial findings at 3.0 Tesla. Acad. Radiol. 2008; 15(6): 776-785.
19. 3He magnetic resonance functional imaging semiautomated segmentation. Acad. Radiol. 2012; 19(2): 141-152.
20. Tustison NJ, Altes TA, Song G, de Lange EE, Mugler JP, III, Gee JC. Feature analysis of hyperpolarized helium-3 pulmonary MRI: a study of asthmatics versus nonasthmatics. Magn. Reson. Med. 2010; 63(6): 1448-1455.
21. Tustison NJ, Avants BB, Flors L, Altes TA, de lange EE, Mugler JP, III, Gee JC. Ventilation-based segmentation of the lungs using hyperpolarized He-3 MRI. J. Magn. Reson. Imaging 2011; 34(4): 831-841.
22. 3He MRI. J. Appl. Physiol. 2009; 106(3): 813-822.
23. 3He MR imaging. Radiology 2010; 256(1): 280-289.
24. 3He MR imaging. Radiology 2011; 261(1): 283-292.
25. Kramer D. DOE begins rationing helium-3. Phys. Today 2010; 63: 6.
26. 129Xe MRI: a viable functional lung imaging modality? Eur. J. Radiol. 2007; 64: 335-344.
27. 129Xe at 0.2T. Acad. Radiol. 2008; 15(6): 713-727.
28. 129Xe MR imaging in healthy volunteers and patients. Radiology 2012; 262(1): 279-289.
29. 129Xe MRI in healthy volunteers and subjects with chronic obstructive pulmonary disease. Magn. Reson. Med. 2011; 65(4): 1154-1165.
30. 129Xe. Appl. Phys. Lett. 1996; 69(12): 1668-1670.
31. 3He lung ventilation imaging with B-1-inhomogeneity correction in a single breath-hold scan. Magn. Reson. Mater. Phys. Biol. Med. 2004; 16(5): 218-226.
32. Horn BKP. Closed-form solution of absolute orientation using unit quaternions. J. Opt. Soc. Am. A 1987; 4(4): 629-642.
33. Drazen JM, Loring SH, Ingram RH. Distribution of pulmonary resistance: effects of gas-density, viscosity, and flow rate. J. Appl. Physiol. 1976; 41(3): 388-395.
34. 81mKr SPECT in chronic obstructive pulmonary disease. Eur. J. Nucl. Med. Mol. Imaging 2005; 32(4): 448-457.
35. Marshall H, Deppe MH, Parra-Robles J, Hillis S, Billings CG, Rajaram S, Swift A, Miller SR, Watson JH, Wolber J, Lipson DA, Lawson R, Wild JM. Direct visualisation of collateral ventilation in COPD with hyperpolarised gas MRI. Thorax 2012; 67(7): 613-617.
36. 1H MR images of the lungs - maximising mutual anatomical and functional information. NMR Biomed. 2011; 24(2): 130-134.
37. Campana L, Kenyon J, Zhalehdoust-Sani S, Tzeng Y-S, Sun Y, Albert M, Lutchen KR. Probing airway conditions governing ventilation defects in asthma via hyperpolarized MRI image functional modeling. J. Appl. Physiol. 2009; 106(4): 1293-1300.
38. 3He lung MRI for regional evaluation of interventional therapy: a pilot study in pediatric cystic fibrosis. J. Magn. Reson. Imaging 2009; 30(5): 981-988.
39. 129Xe MR imaging of alveolar gas uptake in humans. PLoS One 2010; 5(8): e12192.
40. Mugler JP, III, Altes TA, Ruset IC, Dregely IM, Mata JF, Miller GW, Ketel S, Ketel J, Hersman FW, Ruppert K. Simultaneous magnetic resonance imaging of ventilation distribution and gas uptake in the human lung using hyperpolarized xenon-129. Proc. Natl. Acad. Sci. USA 2010; 107(50): 21 707-21 712.